-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Edwards Lifesciences, Lowers Price Target to $89

Benzinga·02/11/2026 16:21:41
Listen to the news
Truist Securities analyst Richard Newitter maintains Edwards Lifesciences (NYSE:EW) with a Hold and lowers the price target from $92 to $89.